USPTO issues Patent for ground breaking polysaccharide technology platform to Endomedix.
Posted: January 9, 2020Montclair, NJ, January 8, 2020 – Endomedix announced today that it received a patent of 30 issued claims for its PLEXimine™ Polysaccharide Technology platform for a new class of biomaterials. The patent, “Methods and Compositions for Achieving Hemostasis and Stable Clot Formation”, also covers design features and mechanisms of action for its first product based […]
Read More ›